scPharmaceuticals Inc. to Present at the 9th Annual SVB Leerink Global Healthcare Conference
February 20 2020 - 8:00AM
Business Wire
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company
focused on developing and commercializing products that have the
potential to optimize the delivery of infused therapies, advance
patient care and reduce healthcare costs, today announced that John
Tucker, president and chief executive officer, will present at the
9th Annual SVB Leerink Global Healthcare Conference at 10:00 a.m.
ET on Tuesday, February 25, 2020, at the Lotte New York Palace
Hotel in New York, NY.
Investors interested in arranging a meeting with the Company’s
management during this conference should contact the conference
coordinator.
About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on
developing and commercializing products that are designed to reduce
healthcare costs and improve health outcomes. The Company develops,
internally and through strategic partnerships, innovative products
and solutions that aim to expand and advance the outpatient care of
select acute conditions. The Company’s lead programs focus on the
subcutaneous, self-administration of IV-strength treatments in
heart failure and infectious disease. scPharmaceuticals is
headquartered in Burlington, MA. For more information, please visit
www.scPharmaceuticals.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200220005113/en/
Katherine Taudvin scPharmaceuticals Inc., 781-301-6706
ktaudvin@scpharma.com
Christopher F. Brinzey Westwicke, an ICR Company, 339-970-2843
chris.brinzey@westwicke.com
scPharmaceuticals (NASDAQ:SCPH)
Historical Stock Chart
From Mar 2024 to Apr 2024
scPharmaceuticals (NASDAQ:SCPH)
Historical Stock Chart
From Apr 2023 to Apr 2024